tag long-covid 
Rethinking Clinical Trials
APRIL 18, 2023
RECOVER has used cohort data to identify major symptom clusters and develop 5 platform protocols that will investigator priority symptom clusters and their causes; test known and novel interventions across domains; and evaluate treatments to improve Long COVID symptoms. It’s all over the place.
Rethinking Clinical Trials
NOVEMBER 1, 2022
HERO Registry; HERO TOGETHER; Hydroxychloroquine; COVID-19; PCORI; PCORnet. On March 21, 2020, in response to the COVID-19 pandemic, PCORI contacted leadership at Duke Clinical Research Institute and PCORnet and a decision was made to focus on the space of healthcare workers. Vanderbilt University Medical Center. Key Points.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 31, 2021
Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial. The study found that Clover’s adjuvanted S-Trimer COVID-19 vaccine candidates were well tolerated and safe. CHENGDU, China , Feb.
XTalks
JULY 16, 2021
A growing trend toward plant-based eating and distrust in the safety of meat brought on by the COVID-19 pandemic has transformed plant-based meat into a popular alternative rather than a niche product enjoyed only by vegans and vegetarians. But yet, the price tag is still higher than real meat. How Long Will Price Parity Take?
XTalks
NOVEMBER 10, 2020
Despite enhanced safety measures brought on by the COVID-19 pandemic, consumers are still skeptical about the safety, source and quality of the foods they buy, according to a new survey. Food fraud is a $40 billion a year problem and ends up costing companies much more to repair the damage done to their reputations in the long run.
pharmaphorum
NOVEMBER 27, 2022
Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Automation will be a large part of this long-term vision.
Delveinsight
FEBRUARY 23, 2021
The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. Moreover, Clover plans to initiate a global phase II/III efficacy trial for SCB-2019 (S-Trimer), its COVID-19 vaccine candidate, in the first half of 2021.
Expert insights. Personalized for you.
219 
Let's personalize your content